Topic: Cardiovascular
Conditions
Interventions
Development of risk model, Identifying the Nature of Risk and Developing Prediction Models
1. To develop one or more multi-dimensional risk stratification models to identify patients w
Sponsors
Hull and East Yorkshire Hospitals NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria for the Risk Stratification Component: 1. Age >18 years 2. In hospital 3. Usual residence is in the catchment region for Hull & East Yorkshire Hospitals Trust (this enables efficient follow-up) 4. Either 4.1. Treated with loop diuretics Or 4.2.Clinical diagnosis of heart failure 5. Willing and able to provide informed consent Additional Inclusion Criteria for the Monitoring Component of the Study: Heart failure as a dominant diagnosis meaning that 1. There is objective evidence of cardiac dysfunction as evidenced by a least ONE of the following: 1.1. Left ventricular ejection fraction 4.0 cm (or >2.5 cm/m in height) 1.3. NT ? ProBNP > 400pg/ml (>47.3pmol/L (or BNP >150 pg/ml) if in sinus rhythm or >1,200pg/ml (or BNP >450pg/ml) if in atrial fibrillation 2. The patient is receiving loop diuretics 3. Target Gender: Male & Female ; Lower Age Limit 80 years
Exclusion criteria
Exclusion criteria: Unable to understand and comply with protocol or to give informed consent. There are no other exclusion criteria for the risk stratification study. Additional Exclusion Criteria for the Monitoring Component of the Study: The duration of admission is likely to be determined by the need for treatment other than for heart failure (for instance, patients with infective endocarditis, major stroke disability or major cognitive impairment will be excluded).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients with an ?optimal length of stay?; Timepoint(s): Discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
United Kingdom
Outcome results
None listed